Category: Baxter InternationalSyndicate content

Baxter names its pharma spinout: Baxalta

September 11, 2014 by Arezu Sarvestani

Baxter's has 'high' hopes for its coming Baxalta spinout, which will get a full visual work-up before the company goes live mid-2015.

Baxter names its pharma spinout: Baxalta

Baxter (NYSE:BAX) crept a little closer to spinning out its biopharmaceuticals division into an independent entity by giving the company a name: Baxalta.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Failure of Medtronic's Symplicity-3 trial doesn't mean the end of renal denervation for hypertension | Medtech Wall Street news for the week of September 1, 2014

September 4, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Renal denervation isn't dead, despite Medtronic trial's failure; Baxter says HQ will stay in Illinois, stays coy on Boston plans; Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity

Renal denervation isn't dead, despite Medtronic trial's failure

September 2, 2014 by Brad Perriello

Baxter says HQ will stay in Illinois, stays coy on Boston plans

August 29, 2014 by Brad Perriello

Baxter International says it will keep its headquarters in Illinois, despite recent reports of a possible move to Boston, but stays coy on its actual plans in The Hub.

Baxter says HQ will stay in Illinois, stays coy on Boston plans

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Is Baxter moving to Massachusetts? | MassDevice.com On Call

August 28, 2014 by Arezu Sarvestani

The Boston Business Journal reports that Baxter International is moving its corporate headquarters from Deerfield, Ill. to Cambridge, Mass.

MassDevice.com On Call

MASSDEVICE ON CALL — Healthcare industry giant Baxter (NYSE:BAX) is moving its corporate headquarters to Massachusetts in a sneaky plot dubbed "Project Tiger" by Bay State economic and business officials, according to a Boston Business Journal report.

Baxter adds 200 jobs in Alabama expansion

August 20, 2014 by Arezu Sarvestani

Baxter will more than double its Opelika, Ala., workforce after putting $300 million into expanding its dialyzer manufacturing facility.

Baxter adds 200 jobs in Alabama expansion

Medtech titan Baxter (NYSE:BAX) is looking to hire 200 new workers to man its growing facility in Alabama as global demand grows for hemodialysis devices.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Baxter recalls dialysis solution over contamination concerns

August 18, 2014 by Arezu Sarvestani

Baxter International recalls 2 lots of its peritoneal dialysis solution after finding potential contamination during the manufacturing process.

Baxter recalls dialysis solution over contamination concerns

Baxter (NYSE:BAX) is pulling back 2 lots of its peritoneal dialysis solution over concerns that the product may have been contaminated during the manufacturing process.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Lack of FDA approval is no longer a deal-breaker for a big exit | The week in medtech M&A

August 6, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Report: Medtech M&A exits don't hinge on FDA approval; White House rails against Medtronic-style corporate inversions; Smith & Nephew CEO: We've been an M&A target for 10 years; More mega-merger talk from medtech giants; Baxter sheds vaccines biz for $635M

Report: Medtech M&A exits don't hinge on FDA approval

July 31, 2014 by Arezu Sarvestani

Report: Medtech M&A no longer hinges on FDA approval
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp